Stock price when the opinion was issued
EPS of 37c beat estimates of 35.7c. Revenue of $130.5M slightly beat estimates of $129.7M. EBITDA of $37.7M beat estimates by 4.6%. Revenue rose 18%. EBITDA rose 13%. Recurring revenue rose 22.8%. Net income rosr 17%. Seachange is being integrated well. Net cash is $245M. Nothing too extraordinary here, but a beat and decent overall growth. Earnings are expected to rise 13% in 2025.
Unlock Premium - Try 5i Free
Small caps get whacked when interest rates rise. If investment-grade companies borrow at 6%, small caps borrow at 10%. Russell 2000 rallied after the election, and has fallen ~8% in December. ENGH has no debt. Strong FCF, dividend grows 15-20% every year.
Q4 earnings were a bit light, so stock's fallen. They also made 2 acquisitions in the quarter. With small caps, you have to be patient. Yield is 3.87%, almost unheard of for a small-cap stock. Switching business model to SaaS, which should improve margins over time and you'll eventually get increased profitability. Stock's at a new 52-week low, and he's buying.
All his past picks on this date were small-caps and chosen, based on him expecting US interest rates to fall. All were turnaround plays. He used dollar-cost averaging. Fading interest in small-caps now, but he still likes ENGH. They are a serial buyer of private companies at good prices. Margins are rising so are increasing the dividend to 4.5%. But they're not large nor liquid. Is adding at these levels.
Not getting much love in the market. Cheaper than almost anything out there, yet keeps getting cheaper. Holding massive amount of excess cash; not using it to increase dividend or buy back shares, so it's in the penalty box. Value tends not to work in tech.
So much other great stuff out there now at reasonable prices.
Shares have fallen since the pandemic, but they've re-created themselves and changed their business model. Like MSFT, they stopped selling software and license it through subscriptions. So operating margins are starting to rise and they just raised the dividend by 18%. Also, they have strong free cash flows and the dividend is growing from 3.5%, rare for a smallcap.
(Analysts’ price target is $38.00)